HK1092727A1 - Biodegradable polyacetals for in vivo polynucleotide delivery - Google Patents

Biodegradable polyacetals for in vivo polynucleotide delivery

Info

Publication number
HK1092727A1
HK1092727A1 HK06113696.4A HK06113696A HK1092727A1 HK 1092727 A1 HK1092727 A1 HK 1092727A1 HK 06113696 A HK06113696 A HK 06113696A HK 1092727 A1 HK1092727 A1 HK 1092727A1
Authority
HK
Hong Kong
Prior art keywords
polynucleotide delivery
vivo polynucleotide
polyacetals
biodegradable
vivo
Prior art date
Application number
HK06113696.4A
Other languages
English (en)
Inventor
Van Sang
Jiadong Zhou
Xiaoli Fu
Lei Yu
Original Assignee
Nitto Denko Corp
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Nitto Denko Corp filed Critical Nitto Denko Corp
Publication of HK1092727A1 publication Critical patent/HK1092727A1/xx

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C08—ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
    • C08L—COMPOSITIONS OF MACROMOLECULAR COMPOUNDS
    • C08L59/00—Compositions of polyacetals; Compositions of derivatives of polyacetals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/50—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates
    • A61K47/51—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent
    • A61K47/56—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent the modifying agent being an organic macromolecular compound, e.g. an oligomeric, polymeric or dendrimeric molecule
    • A61K47/59—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent the modifying agent being an organic macromolecular compound, e.g. an oligomeric, polymeric or dendrimeric molecule obtained otherwise than by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyureas or polyurethanes
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/50—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates
    • A61K47/51—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent
    • A61K47/56—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent the modifying agent being an organic macromolecular compound, e.g. an oligomeric, polymeric or dendrimeric molecule
    • A61K47/59—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent the modifying agent being an organic macromolecular compound, e.g. an oligomeric, polymeric or dendrimeric molecule obtained otherwise than by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyureas or polyurethanes
    • A61K47/593—Polyesters, e.g. PLGA or polylactide-co-glycolide
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/50—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates
    • A61K47/51—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent
    • A61K47/56—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent the modifying agent being an organic macromolecular compound, e.g. an oligomeric, polymeric or dendrimeric molecule
    • A61K47/59—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent the modifying agent being an organic macromolecular compound, e.g. an oligomeric, polymeric or dendrimeric molecule obtained otherwise than by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyureas or polyurethanes
    • A61K47/595—Polyamides, e.g. nylon
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K48/00—Medicinal preparations containing genetic material which is inserted into cells of the living body to treat genetic diseases; Gene therapy
    • A61K48/0008—Medicinal preparations containing genetic material which is inserted into cells of the living body to treat genetic diseases; Gene therapy characterised by an aspect of the 'non-active' part of the composition delivered, e.g. wherein such 'non-active' part is not delivered simultaneously with the 'active' part of the composition
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K48/00—Medicinal preparations containing genetic material which is inserted into cells of the living body to treat genetic diseases; Gene therapy
    • A61K48/0008—Medicinal preparations containing genetic material which is inserted into cells of the living body to treat genetic diseases; Gene therapy characterised by an aspect of the 'non-active' part of the composition delivered, e.g. wherein such 'non-active' part is not delivered simultaneously with the 'active' part of the composition
    • A61K48/0025—Medicinal preparations containing genetic material which is inserted into cells of the living body to treat genetic diseases; Gene therapy characterised by an aspect of the 'non-active' part of the composition delivered, e.g. wherein such 'non-active' part is not delivered simultaneously with the 'active' part of the composition wherein the non-active part clearly interacts with the delivered nucleic acid
    • A61K48/0041—Medicinal preparations containing genetic material which is inserted into cells of the living body to treat genetic diseases; Gene therapy characterised by an aspect of the 'non-active' part of the composition delivered, e.g. wherein such 'non-active' part is not delivered simultaneously with the 'active' part of the composition wherein the non-active part clearly interacts with the delivered nucleic acid the non-active part being polymeric
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09—Recombinant DNA-technology
    • C12N15/87—Introduction of foreign genetic material using processes not otherwise provided for, e.g. co-transformation

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Genetics & Genomics (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Epidemiology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Biotechnology (AREA)
  • Molecular Biology (AREA)
  • Organic Chemistry (AREA)
  • Biochemistry (AREA)
  • Biomedical Technology (AREA)
  • Zoology (AREA)
  • Wood Science & Technology (AREA)
  • General Engineering & Computer Science (AREA)
  • Microbiology (AREA)
  • Biophysics (AREA)
  • Physics & Mathematics (AREA)
  • Plant Pathology (AREA)
  • Polymers & Plastics (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Medicinal Preparation (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Saccharide Compounds (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Biological Depolymerization Polymers (AREA)
HK06113696.4A 2003-09-29 2006-12-13 Biodegradable polyacetals for in vivo polynucleotide delivery HK1092727A1 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US50716103P 2003-09-29 2003-09-29
PCT/US2004/030323 WO2005032597A1 (en) 2003-09-29 2004-09-16 Biodegradable polyacetals for in vivo polynucleotide delivery

Publications (1)

Publication Number Publication Date
HK1092727A1 true HK1092727A1 (en) 2007-02-16

Family

ID=34421587

Family Applications (1)

Application Number Title Priority Date Filing Date
HK06113696.4A HK1092727A1 (en) 2003-09-29 2006-12-13 Biodegradable polyacetals for in vivo polynucleotide delivery

Country Status (7)

Country Link
US (2) US7794696B2 (xx)
EP (1) EP1667732B1 (xx)
JP (1) JP4586022B2 (xx)
AT (1) ATE464913T1 (xx)
DE (1) DE602004026747D1 (xx)
HK (1) HK1092727A1 (xx)
WO (1) WO2005032597A1 (xx)

Families Citing this family (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7332477B2 (en) * 2003-07-10 2008-02-19 Nitto Denko Corporation Photocleavable DNA transfer agent
EP1667732B1 (en) 2003-09-29 2010-04-21 Nitto Denko Corporation Biodegradable polyacetals for in vivo polynucleotide delivery
US7446099B2 (en) 2004-02-27 2008-11-04 Nitto Denko Corporation Compositions and methods for biodegradable polymer-peptide mediated transfection
DE102004023117A1 (de) * 2004-05-11 2005-12-08 A. u. K. Müller GmbH & Co KG Elektromagnetventil für flüssige Medien, insbesondere Heißwasser
US7358223B2 (en) * 2004-10-04 2008-04-15 Nitto Denko Corporation Biodegradable cationic polymers
US7674452B2 (en) 2005-03-16 2010-03-09 Nitto Denko Corporation Polymer coating of cells
US7588754B2 (en) 2005-05-10 2009-09-15 Nitto Denko Corporation Biodegradable polyacetals and methods
US20060263328A1 (en) * 2005-05-19 2006-11-23 Sang Van Hydrophilic polymers with pendant functional groups and method thereof
US7700541B2 (en) 2006-04-06 2010-04-20 Nitto Denko Corporation Biodegradable cationic polymers
WO2008127532A1 (en) * 2007-04-12 2008-10-23 Emory University Novel strategies for delivery of active agents using micelles and particles

Family Cites Families (54)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CS254355B1 (en) 1985-04-10 1988-01-15 Vladimir Saudek Soluble and biodegradatable copolymeres activated for bond of biologicaly active substances
US4713441A (en) 1986-08-01 1987-12-15 Sandoz Pharmaceuticals Corp. Polyacetal hydrogels formed from divinyl ethers and polyols
US6258354B1 (en) 1989-09-29 2001-07-10 Joel S. Greenberger Method for homing hematopoietic stem cells to bone marrow stromal cells
EP0474875B1 (en) * 1990-02-27 1995-11-15 Asahi Kasei Kogyo Kabushiki Kaisha Thermoplastic graft copolymer and production thereof
US20030087985A1 (en) 1990-10-15 2003-05-08 Hubbell Jeffrey A. Gels for encapsulation of biological materials
CA2099376A1 (en) 1991-01-03 1992-07-04 Henry E. Auer Stabilization of proteins by cationic biopolymers
DE4142130A1 (de) 1991-12-20 1993-06-24 Basf Ag Verwendung von polyacetalen auf basis von vinylethern und dihydroxyverbindungen in wasch- und reinigungsmitteln und polyacetale
JPH07309943A (ja) 1994-05-16 1995-11-28 Mitsubishi Chem Corp 酸性アミノ酸系樹脂
NO180167C (no) 1994-09-08 1997-02-26 Photocure As Fotokjemisk fremgangsmåte til å innföre molekyler i cellers cytosol
US5811510A (en) * 1995-04-14 1998-09-22 General Hospital Corporation Biodegradable polyacetal polymers and methods for their formation and use
US5902246A (en) 1996-03-26 1999-05-11 Lifespex, Incorporated Method and apparatus for calibrating an optical probe
TW371617B (en) 1996-10-09 1999-10-11 Of Animal And Plant Health Inspection And Quarantine Council Of Agriculture Executive Yuan Bureau Method to transplant GFP into autographa californica multiple nuclear polyhedrosis virus for inflicting pest in an attempt to detect and flow up it existence and to improve life span against UV
US6258351B1 (en) 1996-11-06 2001-07-10 Shearwater Corporation Delivery of poly(ethylene glycol)-modified molecules from degradable hydrogels
EP0959873B1 (en) * 1996-12-20 2006-03-01 ALZA Corporation Gel composition and methods
WO1998048845A1 (en) 1997-04-29 1998-11-05 Nycomed Imaging As Method of demarcating tissue
CA2297025A1 (en) 1997-07-25 1999-02-04 Sdg, Inc. Polymer based pharmaceutical compositions for targeted delivery of biologically active agents
US6383811B2 (en) * 1997-12-30 2002-05-07 Mirus Corporation Polyampholytes for delivering polyions to a cell
US20030113303A1 (en) 1998-02-05 2003-06-19 Yitzhack Schwartz Homing of embryonic stem cells to a target zone in tissue using active therapeutics or substances
US6866842B1 (en) 1998-05-01 2005-03-15 University Of Pittsburgh Muscle-derived cells (MDCs) for treating muscle-or bone-related injury or dysfunction
JPH11335269A (ja) * 1998-05-19 1999-12-07 Hisamitsu Pharmaceut Co Inc 遺伝子関連医薬の経口投与固形製剤
US7396919B1 (en) 1998-07-17 2008-07-08 Mirus Bio Corporation Charge reversal of polyion complexes
US7018654B2 (en) 1999-03-05 2006-03-28 New River Pharmaceuticals Inc. Pharmaceutical composition containing an active agent in an amino acid copolymer structure
US7160924B2 (en) 2002-07-19 2007-01-09 The General Hospital Corporation Protein conjugates with a water-soluble biocompatible, biodegradable polymer
EP1209971A4 (en) 1999-08-20 2004-04-14 Mirus Corp POLYION COMPLEX LOAD INVERSION
CA2388920A1 (en) 1999-11-02 2001-05-10 Canadian Space Agency Photosolubilizable layers
US20020052335A1 (en) * 1999-11-29 2002-05-02 Rozema David B. Charge reversal of polyion complexes
US7033607B2 (en) * 1999-12-31 2006-04-25 Mirus Bio Corporation pH-titratable polyampholytes for delivering polyions to a cell
WO2001049841A1 (en) 1999-12-31 2001-07-12 Mirus Corporation Polyampholytes for delivering polyions to a cell
US6881576B2 (en) * 1999-12-31 2005-04-19 Mirus Bio Corporation Formation of polyampholytes in the presence of a polyion
WO2002015955A2 (en) 2000-08-23 2002-02-28 Surfarc Aps Biocompatible materials
AU2001288829A1 (en) 2000-09-06 2002-03-22 Ap Pharma, Inc. Degradable polyacetal polymers
US6534243B1 (en) 2000-10-23 2003-03-18 Advanced Micro Devices, Inc. Chemical feature doubling process
US20030049320A1 (en) 2000-12-18 2003-03-13 Wockhardt Limited Novel in-situ forming controlled release microcarrier delivery system
US20030120355A1 (en) 2001-06-08 2003-06-26 Urs Hafeli Biocompatible and biodegradable polymers for diagnostic and therapeutic radioisotope delivery
BR0212192A (pt) * 2001-08-15 2004-10-05 Dow Global Technologies Inc Conjunto para interior veicular
JP3493608B2 (ja) * 2001-11-28 2004-02-03 学校法人慶應義塾 医用高分子及びその用途
JP3969109B2 (ja) 2002-02-08 2007-09-05 コニカミノルタホールディングス株式会社 感光性平版印刷版及びその記録方法
AU2003220161A1 (en) 2002-03-12 2003-09-29 Nitto Denko Corporation Vector for transfection of eukaryotic cells
US20030191458A1 (en) 2002-04-03 2003-10-09 Cornelius Diamond Light-activated drug delivery method and device
US20030215395A1 (en) * 2002-05-14 2003-11-20 Lei Yu Controllably degradable polymeric biomolecule or drug carrier and method of synthesizing said carrier
EP1534269B1 (en) 2002-07-19 2013-10-30 The General Hospital Corporation Oxime conjugates and methods for their formation and use
US20040258669A1 (en) 2002-11-05 2004-12-23 Dzau Victor J. Mesenchymal stem cells and methods of use thereof
US6878374B2 (en) * 2003-02-25 2005-04-12 Nitto Denko Corporation Biodegradable polyacetals
US7727969B2 (en) 2003-06-06 2010-06-01 Massachusetts Institute Of Technology Controlled release nanoparticle having bound oligonucleotide for targeted delivery
US7332477B2 (en) 2003-07-10 2008-02-19 Nitto Denko Corporation Photocleavable DNA transfer agent
US7048925B2 (en) * 2003-08-28 2006-05-23 Nitto Denko Corporation Acid-sensitive polyacetals and methods
EP1667732B1 (en) 2003-09-29 2010-04-21 Nitto Denko Corporation Biodegradable polyacetals for in vivo polynucleotide delivery
US7163677B2 (en) 2003-10-24 2007-01-16 Nitto Denko Corporation Cationic polymers having degradable crosslinks
US7368240B2 (en) 2003-11-11 2008-05-06 Nitto Denko Corporation Microscope system and methods for intracellular studies
US7446099B2 (en) 2004-02-27 2008-11-04 Nitto Denko Corporation Compositions and methods for biodegradable polymer-peptide mediated transfection
US7358223B2 (en) 2004-10-04 2008-04-15 Nitto Denko Corporation Biodegradable cationic polymers
US7674452B2 (en) 2005-03-16 2010-03-09 Nitto Denko Corporation Polymer coating of cells
US7588754B2 (en) 2005-05-10 2009-09-15 Nitto Denko Corporation Biodegradable polyacetals and methods
US20060263328A1 (en) 2005-05-19 2006-11-23 Sang Van Hydrophilic polymers with pendant functional groups and method thereof

Also Published As

Publication number Publication date
EP1667732A1 (en) 2006-06-14
EP1667732B1 (en) 2010-04-21
WO2005032597A1 (en) 2005-04-14
US20110015344A1 (en) 2011-01-20
US8383091B2 (en) 2013-02-26
US7794696B2 (en) 2010-09-14
JP2007511465A (ja) 2007-05-10
JP4586022B2 (ja) 2010-11-24
US20050080033A1 (en) 2005-04-14
DE602004026747D1 (de) 2010-06-02
ATE464913T1 (de) 2010-05-15

Similar Documents

Publication Publication Date Title
HK1092727A1 (en) Biodegradable polyacetals for in vivo polynucleotide delivery
WO2007041584A3 (en) Implantable sensors, implantable pumps, and anti-scarring drug combinations
IL179633A0 (en) Drug compositions, fusions and conjugates
WO2008033300A3 (en) Bis (thiohydrazide amides) formulation
EP1587908A4 (en) RELEASE AND ACTIVATION OF COMPLEX CELLS OF POLYPEPTIDES AND NUCLEIC ACIDS
MX2007002189A (es) Sales de dicetopiperazina, sales de dicetomorfolina o sales de dicetodioxano para suministro de farmacos.
SG98393A1 (en) Injectable drug delivery systems with cyclodextrin-polymer based hydrogels
AU2003262623A8 (en) Releasable polymeric conjugates based on aliphatic biodegradable linkers
HK1187826A1 (en) Insulin oligomer conjugates, formulations and uses thereof
ZA200304090B (en) Agricultural articles.
MX252144B (es) Laminados compostable/biodegradables y con capacidad para respirar.
AU2003214133A1 (en) Topical composition comprising a cyclofructan, a carrier and a drug
TW200635576A (en) Releasable polymeric conjugates based on aliphatic biodegradable linkers
HK1102612A1 (en) Polymeric structures and method for making same
WO2003011226A3 (en) Products and drug delivery vehicles
HK1080497A1 (en) Carbohydrate-modified polymers, compositions and uses related thereto
AU2003237288A1 (en) Biodegradable block copolymeric compositions for drug delivery
WO2006055008A3 (en) Implantable sensors and implantable pumps and anti-scarring agents
AU2003256613A8 (en) Protein conjugates with a water-soluble biocompatible, biogradable polymer
EP1809661A4 (en) MUTEIN INTERFERON BETA HUMAN
ZA200407794B (en) Novel biomaterials, their preparation and use.
TW200637171A (en) An interleaver and associated methods
EP1622572A4 (en) CONJUGATES AND COMPOSITIONS FOR CELLULAR DELIVERY
MX2007007355A (es) 5-(2,2-dimetil-ciclopropil)-3-metil-pen-2-en nitrilo como fragancia y sabor.
AU2003272260A8 (en) Verifiable absorption drug delivery form based on cyclodextrins

Legal Events

Date Code Title Description
PC Patent ceased (i.e. patent has lapsed due to the failure to pay the renewal fee)

Effective date: 20150916